Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Plasma omentin-1 levels are related to exercise performance in obese women and increase upon aerobic endurance training.

Wilms B., Ernst B., Gerig R., Schultes B.

Laboratory Study on Hip, published in Exp Clin Endocrinol Diabetes (2015) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Exp Clin Endocrinol Diabetes (2015)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
25789872
DOI
10.1055/s-0034-1398504

Abstract (original English)

Omentin-1 is an adipokine that is primarily released from visceral adipose tissue stromal cells. The effects of exercise on omentin-1 regulation are not clear so far. Therefore, the effect of endurance training on circulating omentin-1 levels and its relation to exercise performance was assessed in obese women. 13 obese women (age: 44.8±3.3 years; BMI: 37.8±1.3 kg·m(-2)) participated in a 6-week endurance training program. Omentin-1, metabolic traits (glucose, insulin, HOMA-IR, lipids profile), and exercise performance (cardiopulmonary exercise test (V̇O2,peak, Wpeak), 6 min walking test, 6MWT) were assessed before and after the training. After the training program circulating omentin-1 were 10.4% higher than before the program (690±50 ng·ml(-1) vs. 618±42; p=0.04), while body weight remained unchanged (p=0.9). Before training, omentin-1 levels were significantly correlated with Wpeak (given in absolute and relative values) as well as with 6MWT (all r≥0.603; all p≤0.029) and the correlations with absolute as well as relativeV̇O2,peak approached significance (both r≥0.534; both p≤0.060). After training, respective correlations were generally weaker and did not reach significance any longer (all r≤0.465; all p≥0.109). Neither before nor after the training program were significant correlations found between omentin-1 levels and the other measured metabolic blood markers (all p≥0.1

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdultCytokinesExercise TherapyFemaleGPI-Linked ProteinsHumansLectinsMiddle AgedObesityPhysical Endurance

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research